Lanean...
Adiponectin Paradox as a Therapeutic Target in Alzheimer’s Disease
Despite the apparent neurotoxicity of amyloid-β (Aβ), recent clinical trials of Aβ immunotherapy have not shown any clinical benefit in Alzheimer’s disease (AD). Given this, clarification of the next generation therapeutic strategy in AD is warranted. Hypothetically, adiponectin might be involved in...
Gorde:
| Argitaratua izan da: | J Alzheimers Dis |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
IOS Press
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7504987/ https://ncbi.nlm.nih.gov/pubmed/32623396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-200416 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|